Viatris (VTRS) Stock Concentration Calculator
Calculator · free · no signup · VTRSQuantify Viatris concentration risk. Drawdown impact at 30 / 50 / 70%, with the tax-aware trade-off between selling down and hedging.
Beta · invite-only · AlphaLatitude Inc. · Free Tools
Your inputs
Adjust — results update instantly.Position & portfolio
Tax
Most fee-only advisors target ≤10% in any single name. You're at 67%.
Estimates only. Not financial advice.
Most sensitive to: Expected market return (±10% on this input swings best-plan wealth by ±$190,508).
Cost of fully de-concentrating
All three plans sell to 0% (no hedge).Sensitivity. If your expected position return drops below 19.6%/yr, lump-sum (sell everything today) beats every spread plan above.
Have multiple RSU vest lots? The RSU Lot Order Calculator picks which lots to sell first, and on which dates, to divest at the lowest computed tax.
Build your own plan
Toggle below — chart updates live. Sell buttons show the slice.Tech / Software single names hit a 50%+ peak-to-trough drawdown in roughly 1 of every 5 rolling 3-year windows over 2014–2024. Even mega-caps aren’t exempt.
Tax brackets: 2026 · Estimates only — not financial advice.
Estate note. Heirs receive a stepped-up basis at death (§1014), eliminating built-in gain on inherited shares. Older holders who plan to bequeath rather than sell may rationally never de-concentrate.
You sized one position's risk. The beta integrates hedging, sell-down, and tax timing into one optimized plan.
Request beta access →Related calculators: Protect Your Stock Calculator · RSU Lot Order Calculator · Equity Funding Plan Calculator
About Viatris
Viatris (VTRS) is a public Pharma/Biotech company, incorporated in Delaware and headquartered in Canonsburg, PA.
Last close: $16.17 per share (as of 2026-08-18).
Equity grants at Viatris typically include restricted stock units (RSUs).
Viatris Inc. is an American global pharmaceutical and healthcare corporation headquartered in Canonsburg, Pennsylvania. The corporation was formed through the merger of Mylan and Upjohn, a legacy division of Pfizer, on November 16, 2020.
Source: Wikipedia (CC BY-SA 4.0)
The company was formed in 2020 by combining Mylan with Upjohn, the off-patent branded division Pfizer separated, producing a portfolio of generics and mature brands rather than a research pipeline. The business is about manufacturing cost, regulatory filings, and distribution scale, not discovery, and revenue declines predictably as products age. Debt reduction and divestiture have taken priority over expansion. Selective investment in complex generics and biosimilars is the attempt to slow the erosion. Headquarters are in Canonsburg, Pennsylvania.
Sources: sec.gov · en.wikipedia.org
OptionsAhoy is an independent tool and is not affiliated with, endorsed by, or sponsored by Viatris.
If a meaningful share of your net worth sits in VTRS, concentration risk is the question. This calculator quantifies drawdown impact at 30 / 50 / 70%, and the trade-off between selling down (tax cost now) versus hedging (option premium drag), auto-filled with VTRS's option-implied volatility.
Example: 5,000 VTRS shares at $16.17 is a $80,850 position. A 30% drawdown costs $24,255; a 50% drawdown costs $40,425; a 70% drawdown costs $56,595. The calculator quantifies the trade-off between selling down (immediate capital-gains tax) and hedging (option premium drag) using VTRS's option-implied volatility and your cost basis.
All Viatris tools → · Use the generic Stock Concentration Calculator for any company. Diversifying multiple RSU lots? See the lot-by-lot sell order →
Viatris equity questions
- How much VTRS stock is too much?
- There is no single threshold, but the larger the share of your net worth in one stock, the more a single bad year can set back your plans. The calculator above quantifies the drawdown impact at 30, 50, and 70 percent for your VTRS position and weighs selling down (which triggers capital-gains tax now) against hedging (which costs option premium).
- Does Viatris grant ISOs, NSOs, or RSUs?
- Equity compensation at Viatris typically takes the form of restricted stock units (RSUs). Restricted stock units are taxed as ordinary income when they vest.
Find another companyPharma/Biotech peers
One piece of the puzzle.
OptionsAhoy plans your Viatris equity alongside hedging, vesting, and de-concentration, across bullish, neutral, and bearish market scenarios. Free during beta.